Low incidence of peripheral arterial disease in patients receiving dasatinib in clinical trials

P. D. Le Coutre, T. P. Hughes, F. X. Mahon, D. W. Kim, J. L. Steegmann, N. P. Shah, K. Gooden, N. Wallis, J. E. Cortes

Research output: Contribution to journalLetter

8 Scopus citations
Original languageEnglish (US)
Pages (from-to)1593-1596
Number of pages4
JournalLeukemia
Volume30
Issue number7
DOIs
StatePublished - Jul 1 2016

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this

Le Coutre, P. D., Hughes, T. P., Mahon, F. X., Kim, D. W., Steegmann, J. L., Shah, N. P., Gooden, K., Wallis, N., & Cortes, J. E. (2016). Low incidence of peripheral arterial disease in patients receiving dasatinib in clinical trials. Leukemia, 30(7), 1593-1596. https://doi.org/10.1038/leu.2015.352